Wolverine Asset Management LLC Novo Cure LTD Call Options Transaction History

Wolverine Asset Management LLC

  • $4.35 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2022

Feb 01, 2023
BUY
$63.98 - $85.37 $946,904 - $1.26 Million
14,800 New
14,800 $1.09 Million
Q3 2018

Nov 14, 2018
SELL
$32.0 - $52.4 $1.6 Million - $2.62 Million
-50,000 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$19.3 - $23.65 $965,000 - $1.18 Million
50,000 New
50,000 $1.09 Million

Others Institutions Holding NVCR

# of Institutions
262
Shares Held
77M
Call Options Held
1.17M
Put Options Held
318K
View Full List

About NovoCure Ltd

NVCR Quotes by TradingView
  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $1.86B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Wolverine Asset Management LLC Portfolio

Follow Wolverine Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email